BioNTech

Stories 21 - 28 | << Prev 

90-Year-Old Grandmother Gets First UK Vaccine
UK Rolls Out Its Vaccine
Dec 8, 2020 6:37 AM CST

UK Rolls Out Its Vaccine

90-year-old grandmother is the first recipient

(Newser) - Margaret Keenan turns 91 next week but already has her gift from the UK government. Keenan was the first person to receive a vaccine dose Tuesday as part of the UK's mass vaccination program , which will be rolling out 800,000 doses of Pfizer and BioNTech's vaccine at...

First Country Approves Pfizer Vaccine

UK to begin vaccinations 'within days'

(Newser) - British officials authorized a COVID-19 vaccine for emergency use on Wednesday, greenlighting the world's first shot against the virus that's backed by rigorous science and taking a major step toward eventually ending the pandemic. The go-ahead for the vaccine developed by Pfizer and BioNTech comes as the virus...

Final Analysis of Pfizer's Vaccine Trials Even Better

Final analysis of late-stage trials shows it's 95% effective, with no major safety worries

(Newser) - More good news from Pfizer and BioNTech, its German partner in the race to produce a coronavirus vaccine: They're expecting to seek an emergency use OK from the Food and Drug Administration "within days," per a statement cited by CNN . That's due to a final analysis...

&#39;Dream Team&#39; Couple Are Behind New Vaccine
'Dream Team' Couple Helped
Develop New Vaccine
THE RUNDOWN
Nov 9, 2020 3:23 PM CST

'Dream Team' Couple Helped Develop New Vaccine

Huge challenges will await after approval

(Newser) - The exhilarating news that a COVID-19 vaccine was a big success in a large-scale trial is a victory for Pfizer—and for the husband-and-wife team behind BioNTech, the German biotech firm that collaborated with the American drugmaker. CEO Ugur Sahin and his wife, board member Oezlem Tuereci, founded the firm...

Pfizer's Update on Vaccine Is a 'Shift in Tone'

Announcement on application for emergency authorization predicts late November at the earliest

(Newser) - Last month, President Trump hinted that a COVID-19 vaccine could be available before Election Day, but the latest news from one of the leading developers seems to make that possibility even more remote. As the Wall Street Journal reports, Pfizer CEO Albert Bourla posted an open letter Friday announcing that,...

In Race for Vaccine, a Cold Truth
In Race for
Vaccine, a
Cold Truth
Sep 18, 2020 12:23 PM CDT

In Race for Vaccine, a Cold Truth

There may not be enough freezers icy enough to store the shots

(Newser) - "Do we have enough freezers?" That's a question many may not be pondering now, but it's an important one when it comes to a COVID-19 vaccine, per the Wall Street Journal . That's because the inoculation samples that may soon emerge might need to be stored at...

Operation Warp Speed Counts a Vaccine Win

Government will pay $1.95B for 100M doses, expected by year's end

(Newser) - The US has inked a deal that will have the country receiving the first 100 million doses of a coronavirus vaccine candidate in the works from Pfizer and German biotech firm BioNTech SE. The government could nab an additional 500 million doses under the agreement, which will see the US...

In Quest for COVID Vaccine, 107K 'Medical Heroes' Emerge

Volunteers coming out in droves to help 4 firms planning on starting phase 3 of clinical trials in fall

(Newser) - In early July, the National Institutes of Health launched a clinical trials network through which it hoped to enroll thousands of volunteers to test potential COVID-19 vaccines. Just a week or so later, more than 107,000 people had signed up. That's a number USA Today says will "...

Stories 21 - 28 | << Prev